Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumour innervation and neurosignalling in prostate cancer.
March B, Faulkner S, Jobling P, Steigler A, Blatt A, Denham J, Hondermarck H. March B, et al. Among authors: steigler a. Nat Rev Urol. 2020 Feb;17(2):119-130. doi: 10.1038/s41585-019-0274-3. Epub 2020 Jan 14. Nat Rev Urol. 2020. PMID: 31937919 Review.
Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADAR.
Ong WL, Nikitas J, Joseph D, Steigler A, Millar J, Valle L, Steinberg ML, Ma TM, Reiter RE, Rettig MB, Nickols NG, Chang A, Zaorsky NG, Spratt DE, Romero T, Kishan AU. Ong WL, et al. Among authors: steigler a. Int J Radiat Oncol Biol Phys. 2024 Jul 1;119(3):813-825. doi: 10.1016/j.ijrobp.2023.09.051. Epub 2023 Oct 4. Int J Radiat Oncol Biol Phys. 2024. PMID: 37802226 Clinical Trial.
Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial.
Delahunt B, Murray JD, Steigler A, Atkinson C, Christie D, Duchesne G, Egevad L, Joseph D, Matthews J, Oldmeadow C, Samaratunga H, Spry NA, Srigley JR, Hondermarck H, Denham JW. Delahunt B, et al. Among authors: steigler a. Histopathology. 2020 Aug;77(2):284-292. doi: 10.1111/his.14107. Epub 2020 Jun 18. Histopathology. 2020. PMID: 32285460
Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial.
Denham JW, Steigler A, Wilcox C, Lamb DS, Joseph D, Atkinson C, Matthews J, Tai KH, Spry NA, Christie D, Gleeson PS, Greer PB, D'Este C; Trans-Tasman Radiation Oncology Group 96.01 Trialists. Denham JW, et al. Among authors: steigler a. Lancet Oncol. 2008 Nov;9(11):1058-68. doi: 10.1016/S1470-2045(08)70236-5. Epub 2008 Oct 15. Lancet Oncol. 2008. PMID: 18929505
Paradoxical metastatic progression following 3 months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancer.
Denham JW, Steigler A, Tai KH, Joseph D, Matthews J, Atkinson C, Spry NA, Turner S, North J, Christie D, Wynne C, Lamb DS. Denham JW, et al. Among authors: steigler a. Radiother Oncol. 2013 May;107(2):123-8. doi: 10.1016/j.radonc.2013.03.025. Epub 2013 Apr 22. Radiother Oncol. 2013. PMID: 23618502 Free article. Clinical Trial.
57 results